Novo Nordisk Reports Strong Phase 2 Zenagamtide Data
PLAINSBORO, N.J. and BAGSVÆRD, Denmark, June 6, 2026 Novo Nordisk has announced positive results from a Phase 2 clinical...
diabetes care
Advertisement
Lupin Wins Tentative FDA Approval for COPD Inhalation Therapy Revefenacin
MUMBAI, India and NAPLES, Fla., May 18, 2026 Lupin Limited has announced that it has received tentative approval from...
Sandoz Secures EC Approval for Bysumlog and Dazparda Diabetes Biosimilars
BASEL, Switzerland, May 15, 2026 Sandoz has announced that the European Commission (EC) granted marketing authorization for two biosimilar...
TempraMed Expands Benelux Access for Temperature-Safe Med Devices
VANCOUVER, BC — December 5, 2025 — TempraMed Technologies Ltd. announced a major expansion into Western Europe through a...
Advertisement
